Log in
Enquire now
Radiomedix

Radiomedix

A biotechnology company developing targeted radiopharmaceuticals for diagnosing, monitoring, and treating cancer.

OverviewStructured DataIssuesContributors

Radiomedix is a biotechnology company developing targeted radiopharmaceuticals for diagnosing, monitoring, and treating cancer that is headquartered in Houston, Texas and was founded in 2006 by Dr. Ebrahim S. Delpassand.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

RadioMedix received $2.0 M SBIR Phase II Contract award from NCI NIH for the targeted alpha-emitter therapy of neuroendocrine cancers.

RadioMedix Inc.

https://www.globenewswire.com/news-release/2019/01/22/1703587/0/en/RadioMedix-received-2-0-M-SBIR-Phase-II-Contract-award-from-NCI-NIH-for-the-targeted-alpha-emitter-therapy-of-neuroendocrine-cancers.html

Web

RadioMedix Receives $1.4 Million Second Tranche Investment from Texas Emerging Technology Fund

RadioMedix Inc.

http://radiomedix.com/press-release/radiomedix-receives-1-4-million-second-tranche-investment-from-texas-emerging-technology-fund/

Web

References

Find more companies like Radiomedix

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.